Clinical trial
Evaluation of Usage Patterns and Outcomes in Patients Receiving Ceftolozane/Tazobactan (C/T) in Brazilian Hospitals
NCT05267483 is registered in ClinicalTrials.gov with D'Or Institute for Research and Education as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Usage Patterns and Outcomes in Patients Receiving Ceftolozane/Tazobactan (C/T) in Brazilian Hospitals
- Lead sponsor
- D'Or Institute for Research and Education
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 1, 2022
- Completion date
- March 30, 2023
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.